US FDA Funds Study To Learn Whether Kratom Users Have ‘Any Risk/Safety Considerations’

Agency says study “intended as a strategic response to understand and characterize emergent risk/safety and perceived benefits reportedly linked to kratom and psychedelics.” Objectives include understanding temporal relationships and correlation of purchase decisions and how marketing strategies nudge purchase and affect use demand.

• Source: Shutterstock

More from Archive

More from HBW Insight